ASIC approves C3 name change

By Dylan Bushell-Embling
Tuesday, 17 June, 2008

The Australian Securities and Investments Commission (ASIC) has approved the request by Clinical Cell Culture (ASX: CCE) to rename itself Avita Medical.

The name change will take effect on June 26, when Avita will begin trading on the ASX under the code AVH.

Heart muscle regeneration genes mapped

Researchers have uncovered insights into how stem cells develop and mature into heart muscle...

The cause of 2022's mpox outbreak revealed

Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...

New gene therapy treats liver disorder in growing children

Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...

Content from other channels on our network

$2.5m to double circuit breaker production in Adelaide

Long-term water security project proposed for Hunter region

Engineering sustainability from the ground up at Selfs Point STP

Complex solar installation for Adelaide wine venue

Australia's data centre plans can become a blueprint for the world

Preserving paediatric data beyond the point of care

Nurse-led infection control training program

Does frailty hold the key to early dementia diagnosis?

Tiny gold particles power golden staph colour test

The cost of not cleaning: how to reduce infections and save money

Funding awarded for electrolyser manufacturing in Port Kembla

GMG announces startup of new graphene production plant

$2.5m to double circuit breaker production in Adelaide

ARENA announces new clean energy startup funding

Peak body wants engineering expertise at the heart of the AI future